Pfizer Canada Inc. v. Apotex Inc., 2017 FC 774

This document cites

• Eli Lilly Canada Inc. v. Mylan Pharmaceuticals ULC et al., (2015) 474 F.T.R. 256 (FC)
• Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., (2008) 381 N.R. 125 (SCC)
• Wenzel Downhole Tools Ltd. et al. v. National-Oilwell Canada Ltd. et al., (2012) 443 N.R. 173 (FCA)
• Pfizer Canada Inc. et al. v. Novopharm Ltd. et al., (2012) 436 N.R. 299 (SCC)
• Allergan Inc. et al. v. Canada (Minister of Health) et al., (2012) 414 F.T.R. 56 (FC)



See all quotations

• Gilead Sciences Inc. et al. v. Canada (Minister of Health) et al., 2016 FC 857
• AstraZeneca Canada Inc. et al. v. Apotex Inc. et al., (2015) 474 N.R. 296 (FCA)
• Whirlpool Corp. et al. v. Camco Inc. et al., (2000) 263 N.R. 88 (SCC)
• Pfizer Canada Inc. et al. v. Canada (Minister of Health) et al., (2007) 366 N.R. 347 (FCA)
• Procter & Gamble v. Can., 2004 FCA 393
• Pfizer Canada Inc. et al. v. Canada (Minister of Health) et al., 2008 FC 11
• AstraZeneca Canada Inc. et al. v. Apotex Inc. et al., (2014) 457 F.T.R. 227 (FC)
• Free World Trust v. Électro Santé Inc. et al., (2000) 263 N.R. 150 (SCC)
• Apotex Inc. v. Sanofi-Aventis, (2013) 447 N.R. 313 (FCA)
• Beloit Canada Ltd. v. Valmet Oy, (1986) 64 N.R. 287 (FCA)
• Monsanto Canada Inc. et al. v. Schmeiser et al., (2004) 320 N.R. 201 (SCC)
• Pfizer Canada Inc. et al. v. Apotex Inc. et al., (2007) 319 F.T.R. 48 (FC)
• GlaxoSmithKline Inc. et al. v. Pharmascience Inc. et al., (2011) 385 F.T.R. 157 (FC)
• Janssen-Ortho Inc. et al. v. Novopharm Ltd., 2007 FCA 217
• Alcon Canada Inc. et al. v. Apotex Inc. et al., (2014) 459 F.T.R. 255 (FC)
• Pfizer Canada Inc. et al. v. Pharmascience Inc. et al., (2013) 427 F.T.R. 6 (FC)
• Pfizer Canada Inc. et al. v. Apotex Inc. et al., (2014) 465 N.R. 306 (FCA)
• Pfizer Canada Inc. et al. v. Apotex Inc. et al., 2007 FC 26
• Eli Lilly Canada Inc. v. Mylan Pharmaceuticals ULC et al., 2015 FCA 286
• Pioneer Hi-Bred Ltd. v. Commissioner of Patents, (1989) 97 N.R. 185 (SCC)
• Abbott Laboratories et al. v. Canada (Minister of Health) et al., (2007) 361 N.R. 308 (FCA)
• Novartis Pharmaceuticals Canada Inc. v. Cobalt Pharmaceuticals Co. et al., (2013) 440 F.T.R. 1 (FC)
• Aventis Pharma Inc. v. Pharmascience, 2006 FCA 229
• Merck & Co. et al. v. Pharmascience Inc. et al., (2010) 368 F.T.R. 1 (FC)
• Pfizer Canada Inc. et al. v. Apotex Inc. et al., 2009 FCA 8
• Bristol-Myers Squibb Canada Co. v. Teva Canada Limited, 2017 FCA 76
• Apotex Inc. v. Eli Lilly Canada Inc., 2016 FCA 267
• Arctic Cat Inc. v. Bombardier Recreational Products Inc., 2016 FC 1047
• Gilead Sciences, Inc. v. Canada (Health), 2016 FC 856
• Teva Canada Ltd. v. Pfizer Canada Inc., 2012 SCC 60